KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Change in Accured Expenses (2021 - 2026)

Bristol Myers Squibb has reported Change in Accured Expenses over the past 6 years, most recently at -$3.5 billion for Q1 2026.

  • Quarterly Change in Accured Expenses fell 457.42% to -$3.5 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$3.3 billion through Mar 2026, down 317.41% year-over-year, with the annual reading at -$441.0 million for FY2025, 129.72% down from the prior year.
  • Change in Accured Expenses was -$3.5 billion for Q1 2026 at Bristol Myers Squibb, down from -$2.4 billion in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $1.8 billion in Q3 2024 and troughed at -$3.5 billion in Q1 2026.
  • The 5-year median for Change in Accured Expenses is -$211.0 million (2023), against an average of -$65.9 million.
  • The largest YoY upside for Change in Accured Expenses was 141.86% in 2022 against a maximum downside of 676.92% in 2022.
  • A 5-year view of Change in Accured Expenses shows it stood at -$303.0 million in 2022, then soared by 30.36% to -$211.0 million in 2023, then plummeted by 91.94% to -$405.0 million in 2024, then crashed by 492.1% to -$2.4 billion in 2025, then plummeted by 45.75% to -$3.5 billion in 2026.
  • Per Business Quant, the three most recent readings for BMY's Change in Accured Expenses are -$3.5 billion (Q1 2026), -$2.4 billion (Q4 2025), and $1.7 billion (Q3 2025).